Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Nitrite for Cerebral Vasospasm
NCT02176837Phase 2Terminated
- Sponsor
- Hope Pharmaceuticals
- Start
- Jun 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium nitrite in cerebral vasospasm, sponsored by Hope Pharmaceuticals. Started Jun 2014; status: terminated.
02
Drugs
sodium nitrite
03
Conditions
cerebral vasospasm
Beyond the preview
Go deeper on NCT02176837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176837.